Anna Rosén

2.2k total citations
52 papers, 1.3k citations indexed

About

Anna Rosén is a scholar working on Genetics, Gastroenterology and Surgery. According to data from OpenAlex, Anna Rosén has authored 52 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 15 papers in Gastroenterology and 14 papers in Surgery. Recurrent topics in Anna Rosén's work include Celiac Disease Research and Management (15 papers), BRCA gene mutations in cancer (12 papers) and Microscopic Colitis (11 papers). Anna Rosén is often cited by papers focused on Celiac Disease Research and Management (15 papers), BRCA gene mutations in cancer (12 papers) and Microscopic Colitis (11 papers). Anna Rosén collaborates with scholars based in Sweden, United States and Netherlands. Anna Rosén's co-authors include Anneli Ivarsson, Annelie Carlsson, Lotta Högberg, Olof Sandström, Fredrik Norström, Anna Myléus, Εva Karlsson, Hans Stenlund, Lars Danielsson and Lars Stenhammar and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Gastroenterology.

In The Last Decade

Anna Rosén

47 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Rosén Sweden 20 711 573 469 309 170 52 1.3k
Ignacio Marín‐Jiménez Spain 22 111 0.2× 734 1.3× 373 0.8× 871 2.8× 125 0.7× 124 1.5k
Dalbir S. Sandhu United States 18 139 0.2× 281 0.5× 473 1.0× 46 0.1× 419 2.5× 50 1.4k
Paula Lago Portugal 18 54 0.1× 380 0.7× 222 0.5× 540 1.7× 216 1.3× 62 934
Vincent Billioud France 11 86 0.1× 789 1.4× 426 0.9× 1.0k 3.3× 81 0.5× 14 1.3k
Tsang-En Wang Taiwan 16 131 0.2× 134 0.2× 334 0.7× 32 0.1× 52 0.3× 53 798
J.J. Keuning Netherlands 12 156 0.2× 127 0.2× 90 0.2× 100 0.3× 86 0.5× 21 879
Robert Allan United States 17 73 0.1× 749 1.3× 556 1.2× 1.1k 3.5× 96 0.6× 55 1.7k
Ahmad Kamal United States 14 426 0.6× 180 0.3× 517 1.1× 33 0.1× 120 0.7× 55 952
Patricia K. Heath United Kingdom 10 45 0.1× 349 0.6× 178 0.4× 536 1.7× 56 0.3× 11 838
Kshama Jaiswal United States 13 81 0.1× 106 0.2× 395 0.8× 42 0.1× 145 0.9× 28 741

Countries citing papers authored by Anna Rosén

Since Specialization
Citations

This map shows the geographic impact of Anna Rosén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Rosén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Rosén more than expected).

Fields of papers citing papers by Anna Rosén

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Rosén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Rosén. The network helps show where Anna Rosén may publish in the future.

Co-authorship network of co-authors of Anna Rosén

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Rosén. A scholar is included among the top collaborators of Anna Rosén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Rosén. Anna Rosén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Stenmark‐Askmalm, Marie, Fredrik Persson, Anna‐Lotta Hallbeck, et al.. (2025). Characterisation of heritable TP53-related cancer syndrome in Sweden—a nationwide study of genotype-phenotype correlations in 90 families. European Journal of Human Genetics. 33(4). 513–522. 1 indexed citations
2.
Grill, Kalle, et al.. (2024). Who has the responsibility to inform relatives at risk of hereditary cancer? A population-based survey in Sweden. BMJ Open. 14(11). e089237–e089237. 1 indexed citations
3.
Rosén, Anna, et al.. (2024). How hereditary cancer risk disclosure to relatives is handled in practice – Patient perspectives from a Swedish cancer genetics clinic. Patient Education and Counseling. 126. 108319–108319. 4 indexed citations
4.
Öfverholm, Anna, Per Karlsson, & Anna Rosén. (2024). The experience of receiving a letter from a cancer genetics clinic about risk for hereditary cancer. European Journal of Human Genetics. 32(5). 539–544. 6 indexed citations
6.
Fritzell, Sara, Anneli Nilsson, Karin Barchan, et al.. (2023). ATOR-1017 (evunzekibart), an Fc-gamma receptor conditional 4-1BB agonist designed for optimal safety and efficacy, activates exhausted T cells in combination with anti-PD-1. Cancer Immunology Immunotherapy. 72(12). 4145–4159. 6 indexed citations
7.
Öfverholm, Anna, Therese Törngren, Anna Rosén, et al.. (2023). Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer. BMC Cancer. 23(1). 738–738. 5 indexed citations
9.
Tham, Emma, Yvonne Brandberg, Håkan Åhlström, et al.. (2022). Whole-Body MRI Surveillance—Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53). Cancers. 14(2). 380–380. 7 indexed citations
11.
Öfverholm, Anna, Hans Ehrencrona, Kalle Grill, et al.. (2020). Public support for healthcare-mediated disclosure of hereditary cancer risk information: Results from a population-based survey in Sweden. Hereditary Cancer in Clinical Practice. 18(1). 18–18. 22 indexed citations
12.
Wiberg, Rebecca, et al.. (2020). Prophylactic Mastectomy: Postoperative Skin Flap Thickness Evaluated by MRT, Ultrasound and Clinical Examination. Annals of Surgical Oncology. 27(7). 2221–2228. 12 indexed citations
13.
Grill, Kalle & Anna Rosén. (2020). Healthcare professionals’ responsibility for informing relatives at risk of hereditary disease. Journal of Medical Ethics. 47(12). e12–e12. 14 indexed citations
14.
15.
Mosley, Adriane, Felipe Vences‐Catalán, Narendiran Rajasekaran, et al.. (2017). Administration of low-dose combination anti-CTLA4, anti-CD137, and anti-OX40 into murine tumor or proximal to the tumor draining lymph node induces systemic tumor regression. Cancer Immunology Immunotherapy. 67(1). 47–60. 25 indexed citations
16.
Kim, Kyoung-Han, Anna Rosén, Samer M. I. Hussein, et al.. (2016). Irx3 is required for postnatal maturation of the mouse ventricular conduction system. Scientific Reports. 6(1). 19197–19197. 45 indexed citations
17.
Wenger, Tara, John P. Dahl, Elizabeth Bhoj, et al.. (2016). Tracheal cartilaginous sleeves in children with syndromic craniosynostosis. Genetics in Medicine. 19(1). 62–68. 22 indexed citations
18.
Rosén, Anna, Renata Auricchio, Jihane Romanos, et al.. (2010). The PreventCD Study design. European Journal of Gastroenterology & Hepatology. 22(12). 1–1. 47 indexed citations
19.
Rosén, Anna, et al.. (2007). Discovery of Selective Small-Molecule CD80 Inhibitors. SLAS DISCOVERY. 12(4). 464–472. 20 indexed citations
20.
Sørensen, Poul, Martin Kussmann, Anna Rosén, et al.. (2004). Identification of Protein-Protein Interfaces Implicated in CD80-CD28 Costimulatory Signaling. The Journal of Immunology. 172(11). 6803–6809. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026